PropThink: SGNT Generic Leucovorin Launches; SPPI Should Absorb the News …
PropThink: SGNT Generic Leucovorin Launches; SPPI Should Absorb The News …
Filed under: drug treatment news articles
By David Moskowitz. Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) have been under pressure as investors await the supply of generic leucovorin to increase and compete with SPPI's branded cancer treatment, Fusilev. … Fusilev is a purer form of …
Read more on Reuters
Monoclonal Antibodies, 1979
Filed under: drug treatment news articles
By the late 1970s, several new biotechnology companies, including Genentech and Hybritech, had already concluded that drugs made with monoclonal antibodies might be used to treat cancer and other diseases. On Jan. 27, 1980, in a front-page article …
Read more on New York Times
PropThink: SGNT Generic Leucovorin Launches; SPPI Should Absorb The News WellBy David Moskowitz Shares of Spectrum Pharmaceuticals (NASDAQ:SPPI) have been under pressure as investors await the supply of generic leucovorin to increase and compete with SPPI`s branded cancer treatment, … Read News